Holly J. Pederson

2.6k total citations
34 papers, 611 citations indexed

About

Holly J. Pederson is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Holly J. Pederson has authored 34 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 14 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Holly J. Pederson's work include BRCA gene mutations in cancer (21 papers), Cancer Risks and Factors (6 papers) and Prenatal Screening and Diagnostics (6 papers). Holly J. Pederson is often cited by papers focused on BRCA gene mutations in cancer (21 papers), Cancer Risks and Factors (6 papers) and Prenatal Screening and Diagnostics (6 papers). Holly J. Pederson collaborates with scholars based in United States, Canada and United Arab Emirates. Holly J. Pederson's co-authors include Charis Eng, Jessica L. Mester, Min-Han Tan, Charissa Peterson, Yiran Yang, Lisa Rybicki, Mohammed S. Orloff, Stephen R. Grobmyer, Ryan Noss and Pelin Batur and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Holly J. Pederson

28 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly J. Pederson United States 11 249 215 128 127 107 34 611
Julian Barwell United Kingdom 14 174 0.7× 337 1.6× 66 0.5× 121 1.0× 213 2.0× 33 749
Jean‐Pierre Fricker France 11 252 1.0× 303 1.4× 99 0.8× 145 1.1× 126 1.2× 15 576
Denise Nebgen United States 13 361 1.4× 334 1.6× 152 1.2× 249 2.0× 192 1.8× 27 915
Kristina G. Flores United States 15 306 1.2× 264 1.2× 41 0.3× 156 1.2× 113 1.1× 21 794
Antoine Daunay France 15 508 2.0× 206 1.0× 50 0.4× 74 0.6× 172 1.6× 26 796
Sevilhan Artan Türkiye 18 308 1.2× 187 0.9× 61 0.5× 69 0.5× 106 1.0× 84 760
Carine Courtillot France 13 206 0.8× 226 1.1× 93 0.7× 90 0.7× 43 0.4× 32 774
Shanna Gustafson United States 12 95 0.4× 290 1.3× 109 0.9× 79 0.6× 173 1.6× 16 636
Christine Pérot France 17 357 1.4× 178 0.8× 75 0.6× 124 1.0× 89 0.8× 31 934
Sally Davies United Kingdom 12 536 2.2× 563 2.6× 97 0.8× 108 0.9× 67 0.6× 16 937

Countries citing papers authored by Holly J. Pederson

Since Specialization
Citations

This map shows the geographic impact of Holly J. Pederson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly J. Pederson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly J. Pederson more than expected).

Fields of papers citing papers by Holly J. Pederson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly J. Pederson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly J. Pederson. The network helps show where Holly J. Pederson may publish in the future.

Co-authorship network of co-authors of Holly J. Pederson

This figure shows the co-authorship network connecting the top 25 collaborators of Holly J. Pederson. A scholar is included among the top collaborators of Holly J. Pederson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly J. Pederson. Holly J. Pederson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pederson, Holly J.. (2025). Considerations for hormone therapy use in survivors of breast cancer. Menopause The Journal of The North American Menopause Society. 32(11). 1060–1062.
2.
Johnson, Justin M., Halle C. F. Moore, Megan Kruse, et al.. (2024). Abstract PO2-17-12: Phase I Trial of alpha-lactalbumin vaccine in high risk operable triple negative breast cancer (TNBC) and patients at high genetic risk for TNBC. Cancer Research. 84(9_Supplement). PO2–17. 1 indexed citations
3.
Pederson, Holly J. & Steven A. Narod. (2024). Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancer. SHILAP Revista de lepidopterología. 2(1). 73–73. 3 indexed citations
4.
Pederson, Holly J., Zahraa Al‐Hilli, & Allison W. Kurian. (2024). Racial disparities in breast cancer risk factors and risk management. Maturitas. 184. 107949–107949. 2 indexed citations
5.
Chichura, Anna, et al.. (2024). Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients. Annals of Surgical Oncology. 31(12). 8372–8382.
6.
Budd, G. Thomas, Justin M. Johnson, Halle C. F. Moore, et al.. (2023). Abstract 3035: Phase I trial of alpha-lactalbumin vaccine in high-risk operable triple-negative breast cancer. Cancer Research. 83(7_Supplement). 3035–3035. 3 indexed citations
7.
Yehia, Lamis, Carol A. Burke, Steven C. Campbell, et al.. (2023). Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants. JAMA Network Open. 6(4). e239705–e239705. 20 indexed citations
8.
AlHilli, Mariam, Pelin Batur, Karen Hurley, et al.. (2023). Comprehensive Care of Women With Genetic Predisposition to Breast and Ovarian Cancer. Mayo Clinic Proceedings. 98(4). 597–609.
9.
10.
Wei, Wei, et al.. (2023). Young Black Women May be More Likely to Have First Mammogram Cancers: A New Perspective in Breast Cancer Disparities. Annals of Surgical Oncology. 30(5). 2856–2869. 5 indexed citations
11.
Lanchbury, Jerry S. & Holly J. Pederson. (2023). An apparent quandary: adoption of polygenics and gene panels for personalised breast cancer risk stratification. PubMed. 1(1). 15–15. 2 indexed citations
12.
13.
Chichura, Anna, et al.. (2021). Lapses in breast cancer screening for highly penetrant mutation carriers during pregnancy and lactation. Journal of Surgical Oncology. 125(4). 589–595. 1 indexed citations
14.
Pederson, Holly J. & Ryan Noss. (2020). Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers. Seminars in Oncology. 47(4). 182–186. 8 indexed citations
15.
Modesitt, Susan C., et al.. (2019). Practical Cancer Genetics and Genomics in Women’s Health. Clinical Obstetrics & Gynecology. 62(4). 687–699.
16.
Faubion, Stephanie S., et al.. (2019). Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy. American Journal of Obstetrics and Gynecology. 222(2). 103–113. 63 indexed citations
17.
Pederson, Holly J., et al.. (2018). Impact of an embedded genetic counselor on breast cancer treatment. Breast Cancer Research and Treatment. 169(1). 43–46. 34 indexed citations
18.
Pederson, Holly J., et al.. (2017). Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core‐needle biopsy. Cancer. 124(3). 459–465. 28 indexed citations
19.
Grobmyer, Stephen R., et al.. (2017). Impact of value based breast cancer care pathway implementation on pre-operative breast magnetic resonance imaging utilization. Gland Surgery. 6(1). 57–63. 8 indexed citations
20.
Pederson, Holly J., Colin O’Rourke, Joanne Lyons, et al.. (2015). Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging. Clinical Breast Cancer. 15(5). 348–352. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julian Barwell Breakdown of academic impact, for papers by Jean‐Pierre Fricker Breakdown of academic impact, for papers by Denise Nebgen Breakdown of academic impact, for papers by Kristina G. Flores Breakdown of academic impact, for papers by Antoine Daunay Breakdown of academic impact, for papers by Sevilhan Artan Breakdown of academic impact, for papers by Carine Courtillot Breakdown of academic impact, for papers by Shanna Gustafson Breakdown of academic impact, for papers by Christine Pérot Breakdown of academic impact, for papers by Sally Davies
Rankless by CCL
2026